We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 14 for:    Viromed
Previous Study | Return to List | Next Study

Phase 3 Gene Therapy for Painful Diabetic Neuropathy

This study is currently recruiting participants.
Verified July 2017 by ViroMed Co., Ltd. dba VM BioPharma
Sponsor:
ClinicalTrials.gov Identifier:
NCT02427464
First Posted: April 28, 2015
Last Update Posted: October 23, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
MedTech Consultants Inc.
Information provided by (Responsible Party):
ViroMed Co., Ltd. dba VM BioPharma
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)